I hold a Master's degree from the University of Bologna and a Ph.D. from Stockholm University. With expertise in ML/AI, biomarker discovery, drug discovery, and bioinformatics, he boasts 13 peer-reviewed publications in journals like Science Translational Medicine and Nature Methods. Leading a bioinformatics team, Marco focuses on target identification, biomarker discovery, and genomic medicine, pushing the boundaries with new technologies. His leadership at Abzu contributes to biomarker-based enrichment strategies for major pharmaceutical companies. As a key member of the Scientific Advisory Board at Genetoo, he guides the AI department, optimizing laser parameters and enhancing the understanding of bacterial attachment and proliferation on diverse surfaces and materials.More...